What antibiotic regimen is appropriate for a urinary tract infection caused by Citrobacter youngae and Enterococcus faecalis in a patient with a glomerular filtration rate of 40 mL/min?

Antibiotic Selection for Polymicrobial UTI with Citrobacter youngae and Enterococcus faecalis (GFR 40)

For this polymicrobial UTI with both Citrobacter youngae and Enterococcus faecalis in a patient with moderate renal impairment (GFR 40), I recommend high-dose oral amoxicillin 500 mg IV/PO every 8 hours for 5-7 days, with dose adjustment based on susceptibility testing results. This provides coverage for both organisms while being renally appropriate.

Rationale for Dual Pathogen Coverage

This is a challenging polymicrobial infection requiring coverage of both a gram-negative (Citrobacter) and gram-positive (Enterococcus) organism. The key is selecting an agent that covers both pathogens while accounting for the moderate renal impairment.

Coverage for Enterococcus faecalis

Enterococcus faecalis is the more straightforward pathogen to address. According to 2022 guidelines, for uncomplicated UTIs due to enterococci (including VRE), several options exist 1:

• High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg IV/PO every 8 hours is specifically recommended for uncomplicated UTIs due to enterococci (2D recommendation) 1
• Nitrofurantoin 100 mg PO every 6 hours is also recommended (2D) 1
• Fosfomycin 3 g PO single dose is an alternative (2D) 1
• Linezolid 600 mg IV/PO every 12 hours is recommended with strong evidence for enterococcal infections (1C) 1

Recent 2025 data confirms that high-dose oral amoxicillin is the preferred treatment for febrile UTIs caused by E. faecalis, with 86% of French infectious disease physicians choosing it as first-line 2.

Coverage for Citrobacter youngae

Citrobacter species require gram-negative coverage. According to 2014 evidence, various antibiotics including aminoglycosides, carbapenems, cephalosporins, and quinolones are used for Citrobacter infections 3. However, the specific agent must be chosen based on susceptibility patterns.

The Optimal Choice: Amoxicillin

Amoxicillin emerges as the single agent that can cover both organisms, assuming susceptibility:

• Covers E. faecalis reliably with guideline-level evidence 1, 2
• Can cover Citrobacter youngae if susceptible (many Citrobacter species retain susceptibility to aminopenicillins, though this must be confirmed)
• Renally appropriate at GFR 40: Standard dosing can be used with GFR >30 mL/min
• Treatment duration: 5-7 days for complicated UTI 1

Alternative Regimens if Amoxicillin Resistance

If susceptibility testing shows resistance to amoxicillin for either organism, consider these alternatives:

Option 1: Nitrofurantoin (if uncomplicated cystitis)

• Nitrofurantoin 100 mg PO every 6 hours for 5 days 1, 4
• Covers both E. faecalis (guideline-supported) 1 and many Citrobacter species
• Safe at GFR 40: Recent 2015 evidence demonstrates that nitrofurantoin remains effective even with GFR as low as 38 mL/min 5
• Critical caveat: Only appropriate for uncomplicated cystitis, NOT for pyelonephritis or systemic infection (inadequate tissue penetration)

Option 2: Combination Therapy for Complicated/Severe Cases

If this is a complicated UTI or pyelonephritis requiring broader coverage:

Ceftriaxone 1-2 g IV daily PLUS Linezolid 600 mg IV/PO every 12 hours

• Ceftriaxone covers Citrobacter (and most gram-negatives) 4
• Linezolid provides robust enterococcal coverage (1C recommendation) 1
• Both agents are renally safe at GFR 40 with minimal dose adjustment needed
• Duration: 5-7 days for UTI 1

Option 3: Fluoroquinolone (if susceptible)

• Levofloxacin 750 mg daily (dose-adjust to 750 mg every 48 hours at GFR 40)
• May cover both organisms if susceptibility confirmed
• However, 37% of infectious disease physicians consider fluoroquinolones inappropriate for E. faecalis UTIs 2, and resistance rates are rising 6

Critical Renal Dosing Considerations at GFR 40

With GFR 40 mL/min (CKD Stage 3b), dose adjustments are essential:

• Amoxicillin: Standard dosing acceptable (GFR >30)
• Nitrofurantoin: Safe and effective at GFR 40 5
• Linezolid: No dose adjustment needed
• Ceftriaxone: No dose adjustment needed
• Aminoglycosides: AVOID or use with extreme caution - once-daily dosing with extended intervals (up to 3 days between doses) if absolutely necessary 7, but nephrotoxicity risk is substantial

Common Pitfalls to Avoid

1. Do NOT use aminoglycosides as monotherapy - while guidelines support single-dose aminoglycosides for simple cystitis due to resistant organisms 1, the GFR 40 significantly increases nephrotoxicity risk, and they provide inadequate enterococcal coverage alone

2. Do NOT assume all beta-lactams cover Citrobacter - many Citrobacter species produce AmpC beta-lactamases; verify susceptibility before using cephalosporins

3. Do NOT use fosfomycin for pyelonephritis - while effective for cystitis, oral fosfomycin lacks strong data for upper tract infections 4

4. Do NOT treat asymptomatic bacteriuria - if the patient is asymptomatic, treatment may not be indicated regardless of culture results

Verification Steps Before Treatment

Before initiating therapy, obtain:

1. Susceptibility testing results - essential for polymicrobial infections
2. Clinical syndrome classification - uncomplicated cystitis vs. pyelonephritis vs. complicated UTI determines agent selection and duration
3. Baseline creatinine - to calculate precise GFR and monitor for nephrotoxicity
4. Urological abnormalities - presence of obstruction, stones, or catheter changes management

The final antibiotic choice must be guided by susceptibility results, but amoxicillin 500 mg every 8 hours represents the most rational empiric choice pending those results, providing dual coverage with an excellent safety profile at GFR 40.